LB Pharmaceuticals Inc
LBRX
$47.78
$3.517.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -170.83% | -66.09% | -222.61% | 30.12% | 4.10% |
| Total Depreciation and Amortization | 18.29% | -3.53% | 4.94% | 4.52% | -1.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 129.59% | -13.54% | 1,314.07% | 26.75% | 218.94% |
| Change in Net Operating Assets | 222.81% | 29.16% | -9,724.74% | 95.18% | 27.34% |
| Cash from Operations | -61.57% | -28.65% | -436.70% | 50.87% | 15.53% |
| Capital Expenditure | -1,034.38% | 20.00% | -- | 100.00% | 71.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -1,893.08% | -50.00% |
| Cash from Investing | 378.13% | 20.00% | 99.91% | -1,897.39% | -49.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.95% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.92% | -429.74% | 95.18% | -- | -- |
| Cash from Financing | -100.02% | 8,119.74% | -100.39% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.27% | 465.09% | -107.56% | 5,945.20% | -38.87% |